Literature DB >> 28634218

High-Quality Statin Trials Support the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines After the HOPE-3 Trial (Heart Outcomes Prevention Evaluation-3): MESA (The Multiethnic Study of Atherosclerosis).

Martin Bødtker Mortensen1, Matthew Budoff2, Dong Li2, Khurram Nasir2, Michael J Blaha2, Veit Sandfort2, Carlos Jose Rodriguez2, Pamela Ouyang2, Erling Falk2.   

Abstract

Entities:  

Keywords:  cardiovascular diseases; guideline; hydroxymethylglutaryl-CoA reductase inhibitors; lipoproteins; primary prevention

Mesh：

Substances：

Year:  2017        PMID： 28634218      PMCID： PMC5845782          DOI： 10.1161/CIRCULATIONAHA.117.029381

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.

Authors:  Jelena Pavlovic; Philip Greenland; Jaap W Deckers; Jasper J Brugts; Maryam Kavousi; Klodian Dhana; M Arfan Ikram; Albert Hofman; Bruno H Stricker; Oscar H Franco; Maarten J G Leening
Journal:  JAMA Cardiol       Date:  2016-09-01       Impact factor: 14.676

2.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson; Karen M Eddleman; Nicole M Jarrett; Ken LaBresh; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

3.  Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy.

Authors:  Martin B Mortensen; Shoaib Afzal; Børge G Nordestgaard; Erling Falk
Journal:  J Am Coll Cardiol       Date:  2015-12-22       Impact factor: 24.094

4.  Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Authors:  Salim Yusuf; Jackie Bosch; Gilles Dagenais; Jun Zhu; Denis Xavier; Lisheng Liu; Prem Pais; Patricio López-Jaramillo; Lawrence A Leiter; Antonio Dans; Alvaro Avezum; Leopoldo S Piegas; Alexander Parkhomenko; Katalin Keltai; Matyas Keltai; Karen Sliwa; Ron J G Peters; Claes Held; Irina Chazova; Khalid Yusoff; Basil S Lewis; Petr Jansky; Kamlesh Khunti; William D Toff; Christopher M Reid; John Varigos; Gregorio Sanchez-Vallejo; Robert McKelvie; Janice Pogue; Hyejung Jung; Peggy Gao; Rafael Diaz; Eva Lonn
Journal:  N Engl J Med       Date:  2016-04-02       Impact factor: 91.245

5.  A trial-based approach to statin guidelines.

Authors:  Paul M Ridker; Peter W F Wilson
Journal:  JAMA       Date:  2013-09-18       Impact factor: 56.272
  5 in total
  1 in total

1.  Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat.

Authors:  Martin Bødtker Mortensen; Børge Grønne Nordestgaard
Journal:  JAMA Cardiol       Date:  2019-11-01       Impact factor: 14.676
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.